18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity

  • Jeong Won Lee
  • Bom Sahn Kim
  • Dong Soo Lee
  • June-Key Chung
  • Myung Chul Lee
  • Soonhag Kim
  • Won Jun Kang
Original Article



The aim of the study was to assess the accuracy of 18F-fluorodeoxyglucose (FDG) PET/CT in mediastinal lymph node staging of patients with non-small-cell lung cancer (NSCLC) in a region with a high prevalence of granulomatous disease.


Between March 2004 and February 2006, all patients with NSCLC underwent FDG PET/CT and contrast-enhanced thoracic CT, and subsequent surgical resection. PET/CT and contrast-enhanced CT images of 182 patients (126 men and 56 women; mean age 60.7 years) with NSCLC were acquired. Mediastinal node staging was determined using the American Joint Committee on Cancer (AJCC) staging system. Surgical and histological findings served as the reference standard.


A total of 182 patients with 778 mediastinal node stations were evaluated. Sensitivity and specificity of contrast-enhanced CT were 36% and 80% on a per-patient basis and 23% and 92% on a per-node station basis. Sensitivity and specificity of PET/CT were 81% and 73% on a per-patient basis and 75% and 85% on a per-node station basis. After lymph nodes with calcification and bilateral hilar distribution were considered benign, sensitivity and specificity of PET/CT were 75% and 89% on a per-patient basis and 66% and 96% on a per-node station basis.


This prospective study suggests that FDG PET/CT can more accurately stage mediastinal lymph nodes than CT. Considering lymph node calcification and distribution pattern could improve specificity at the cost of a decrease in sensitivity.


Lung cancer Positron emission tomography (PET) 18F-Fluorodeoxyglucose (FDG) Staging 


  1. 1.
    Halter G, Buck AK, Schirrmeister H, Aksoy E, Liewald F, Glatting G, et al. Lymph node staging in lung cancer using [18F] FDG-PET. Thorac Cardiovasc Surg 2004;52:96–101. doi:10.1055/s-2004-817844.CrossRefPubMedGoogle Scholar
  2. 2.
    Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer; the guidelines. Chest 2003;123:147–56. doi:10.1378/chest.123.1_suppl.147S.CrossRefGoogle Scholar
  3. 3.
    Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging handbook. 6th ed. New York, NY: Springer Verlag; 2002.Google Scholar
  4. 4.
    Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre-Finn C. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment. Clin Lung Cancer 2008;9:92–101. doi:10.3816/CLC.2008.n.014.CrossRefPubMedGoogle Scholar
  5. 5.
    Tieu BH, Sanborn RE, Thomas CR Jr. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin 2008;18:403–15. doi:10.1016/j.thorsurg.2008.07.004.CrossRefPubMedGoogle Scholar
  6. 6.
    Kamiyoshihara M, Kawashima O, Ishikawa S, Morishita Y. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer. J Cardiovasc Surg (Torino) 2001;42:119–24.Google Scholar
  7. 7.
    Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J 1997;10:1547–51. doi:10.1183/09031936.97.10071547.CrossRefPubMedGoogle Scholar
  8. 8.
    McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JO, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319–23.PubMedGoogle Scholar
  9. 9.
    Hoh CK, Schieppers C, Seltzer MA, Gambhir SS, Silverman DH, Czernin J, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997;27:94–106. doi:10.1016/S0001-2998(97) 80042-6.CrossRefPubMedGoogle Scholar
  10. 10.
    Rohren EM, Turkington TG, Coleman RE. Clinical application of PET in oncology. Radiology 2004;231:305–32. doi:10.1148/radiol.2312021185.CrossRefPubMedGoogle Scholar
  11. 11.
    Farrell MA, McAdams HP, Herndon JE, Patz EF Jr. Non-small cell lung cancer: FDG-PET for node staging in patients with stage I disease. Radiology 2000;215:886–90.PubMedGoogle Scholar
  12. 12.
    Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging and management of non-small cell lung cancer. Oncologist 2004;9:633–43. doi:10.1634/theoncologist.9-6-633.CrossRefPubMedGoogle Scholar
  13. 13.
    Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254–61. doi:10.1056/NEJM200007273430404.CrossRefPubMedGoogle Scholar
  14. 14.
    Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861–6. doi:10.1016/S0003-4975(03)00888-9.CrossRefPubMedGoogle Scholar
  15. 15.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005;236:1011–9. doi:10.1148/radiol.2363041310.CrossRefPubMedGoogle Scholar
  16. 16.
    Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated F-FDG PET/CT in a tuberculosis-endemic country. Cancer 2007;109:1068–77. doi:10.1002/cncr.22518.CrossRefPubMedGoogle Scholar
  17. 17.
    Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718–23. doi:10.1378/chest.111.6.1718.CrossRefPubMedGoogle Scholar
  18. 18.
    Ko JP, Drucker EA, Shepard JA, Mountain CF, Dresler C, Sabloff B, et al. CT depiction of regional node stations for lung cancer staging. AJR Am J Roentgenol 2000;174:775–82.PubMedGoogle Scholar
  19. 19.
    Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT – a prospective study. Radiology 2006;241:501–9. doi:10.1148/radiol.2412051173.CrossRefPubMedGoogle Scholar
  20. 20.
    Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710–7. doi:10.1378/chest.111.6.1710.CrossRefPubMedGoogle Scholar
  21. 21.
    Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998;2:27–36.PubMedGoogle Scholar
  22. 22.
    Yen RF, Chen KC, Lee JM, Chang YC, Wang J, Cheng MF, et al. 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging 2008;35:1305–15. doi:10.1007/s00259-008-0733-1.CrossRefPubMedGoogle Scholar
  23. 23.
    Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123:157S–66S. doi:10.1378/chest.123.1_suppl.157S.CrossRefPubMedGoogle Scholar
  24. 24.
    Cerfolio RJ, Ojha B, Bryant AS, Raqhuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017–23. doi:10.1016/j.athoracsur.2004.02.067.CrossRefPubMedGoogle Scholar
  25. 25.
    Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–7. doi:10.1056/NEJMoa022136.CrossRefPubMedGoogle Scholar
  26. 26.
    Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 2004;125:2300–8. doi:10.1378/chest.125.6.2300.CrossRefPubMedGoogle Scholar
  27. 27.
    Fischer BM, Mortensen J, Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2001;2:659–66. doi:10.1016/S1470-2045(01) 00555-1.CrossRefPubMedGoogle Scholar
  28. 28.
    Verhagen AF, Bootsma GP, Tian-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, et al. FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer 2004;44:175–81. doi:10.1016/j.lungcan.2003.11.007.CrossRefPubMedGoogle Scholar
  29. 29.
    Hwangbo B, Kim SK, Lee HS, Lee HS, Kim MS, Lee JM, et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated positron emission tomography/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2008 [Epub ahead of print].Google Scholar
  30. 30.
    Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409–14. doi:10.1007/BF01367602.CrossRefPubMedGoogle Scholar
  31. 31.
    Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997;113:248–52. doi:10.1016/S0022-5223(97) 70320-9.CrossRefPubMedGoogle Scholar
  32. 32.
    Kang WJ, Chung JK, So Y, Jeong JM, Lee DS, Lee MC. Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours. Eur J Nucl Med Mol Imaging 2004;31:202–7. doi:10.1007/s00259-003-1368-x.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Jeong Won Lee
    • 1
  • Bom Sahn Kim
    • 2
  • Dong Soo Lee
    • 1
  • June-Key Chung
    • 1
  • Myung Chul Lee
    • 1
  • Soonhag Kim
    • 1
  • Won Jun Kang
    • 3
  1. 1.Department of Nuclear Medicine, College of MedicineSeoul National UniversitySeoulKorea
  2. 2.Department of Nuclear Medicine, College of MedicineEwha Woman’s UniversitySeoulKorea
  3. 3.Division of Nuclear Medicine, Department of RadiologyYonsei University College of MedicineSeoulKorea

Personalised recommendations